Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
13 results
  • Colorectal Cancer, Endometrial Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer

20-444          Phase I

A Phase 1, First-in-human Study of the Safety, Single- and Multiple-Dose Pharmacokinetics, and Preliminary Activity of Escalating Doses of RBN-2397, an Oral PARP7 Inhibitor, in Patients with Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Melanoma, Ovarian Cancer, Endometrial Cancer, Uterine Cancer, Breast Cancer, Bladder Cancer

22-430          Phase II

A Phase 1/2 First-in-Human Study of the Safety and Efficacy of IMC-F106C as a Single Agent and in Combination with Checkpoint Inhibitors in HLA-A*02:01-Positive Participants with Advanced PRAME-Positive Cancers (View details on clinicaltrial.gov)

  • Endometrial Cancer, Esophageal Cancer, Gastric (Stomach) Cancer, Bladder Cancer, Liver Cancer, Sarcoma, Pancreatic Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation (View details on clinicaltrial.gov)

  • Lung Cancer, Colorectal Cancer, Endometrial Cancer, Ovarian Cancer, Head and Neck Cancer

21-060          Phase II

A Phase 1/2 Study Evaluating the Safety, Tolerability and Preliminary Antitumor Activity of COM701 in Combination with BMS-986207 (anti-TIGIT antibody) and Nivolumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Endometrial Cancer

22-558          Phase II

A Phase 1/2a, Multicenter, Open-Label, Non-Randomized First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1303 in Patients with Advanced/Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Head and Neck Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Endometrial Cancer, Cervical Cancer

22-015          Phase I

A Phase 1a/1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY159 as a SA and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Ovarian Cancer, Endometrial Cancer

18-555          Phase I

A Phase 1a/1b Study of COM701 as Monotherapy and In Combination with an Anti-PD-1 Antibody in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Endometrial Cancer

18-301          Phase II

A Phase 2 Study of Abemaciclib in Combination with Letrozole or in Combination with Letrozole and Metformin in Recurrent or Persistent Endometrial Cancer (View details on clinicaltrial.gov)

  • Endometrial Cancer

19-615          Phase III

A phase 3, Randomized, Double-Blind, Multicenter study of Dostarlimab (TSR-042) plus Carboplatin-Paclitaxel versus Placebo plus Carboplatin-Paclitaxel in patients with recurrent or primary advanced Endometrial Cancer (RUBY) (View details on clinicaltrial.gov)

  • Ovarian Cancer, Endometrial Cancer, Head and Neck Cancer, Breast Cancer

21-203          Phase I

A Phase Ib, Open-Label, Dose-Escalation and Dose-Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Inavolisib in Combination with Paclitaxel and With or Without Targeted Therapies in Patients with Locally Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 13 results